(Q36075755)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780040%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

review article

1 reference

title

Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780040%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780040%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

François G

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780040%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Kew MC

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780040%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Leroux-Roels G

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780040%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Meheus A

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780040%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Hoosen AA

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780040%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Mphahlele MJ

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780040%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 April 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780040%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780040%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780040%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780040%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

201-213

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780040%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis B and hepatitis C co-infection in patients with HIV.

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Hepatitis B in patients with HIV infection: relationship to AIDS and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Hepatitis B: an important public health issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Outcome of Hepatitis B Virus Infection in Homosexual Men and Its Relation to Prior Human Immunodeficiency Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Hepatitis B: virus, pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Hepatitis B epidemiology in Asia, the Middle East and Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Hepatitis B virus activation among central Africans infected with human immunodeficiency virus (HIV) type 1: pre-s2 antigen is predominantly expressed in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

The injection century: massive unsterile injections and the emergence of human pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Infant and adolescent hepatitis B immunization up to 1999: a global overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Clinical reactivation of hepatitis B in anti-HBs-positive patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Seroprevalence of hepatitis B and C and HIV in Malawian pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

HBs antigen in children with suspicion of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Evaluation of seroepidemiological associations between HIV-infection, hepatitis B and other sexually transmitted diseases in African patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Hepatitis B and C infections, human immunodeficiency virus and other sexually transmitted infections among women of childbearing age in Côte d'Ivoire, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus, and hepatitis B virus infections among male workers at a sugar estate in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Prevalence of hepatitis B antigens in human immunodeficiency virus type 1 seropositive and seronegative pregnant women in Zambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Seroprevalence of hepatitis B and C, and human immunodeficiency type 1 viruses in a rural population from the Republic of Equatorial Guinea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

HIV, HBV, delta-agent and Treponema pallidum infections in two rural African areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

How AIDS forces reappraisal of hepatitis B virus control in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Occult hepatitis B virus infection and its clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Hepatitis B virus DNA in serum of healthy black African adults positive for hepatitis B surface antibody alone: possible association with recombination between genotypes A and D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Management of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Dynamics of plasma hepatitis B virus levels after highly active antiretroviral therapy in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

The predicted pattern of emergence of vaccine-resistant hepatitis B: a cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Effect of hepatitis B virus mutants on efficacy of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Current status of HBV vaccine escape variants--a mathematical model of their epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X

Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01054.X